Specialities

Speech-language pathologist having lesson with little girl

Ear self-care has been integral to our business from its founding, and we have developed our knowledge of the clinical evidence, product use and patient pathways.

We have particular expertise in areas where appropriate self-care can support patients and reduce unnecessary pressure on clinical services.

This page provides an overview of the clinical areas we work in, the products we represent, and the evidence and professional resources available for healthcare professionals.

Speech-language pathologist having lesson with little girl
Otovent Adult pack

Otitis Media with Effusion (Glue Ear)

Kestrel Medical Ltd has a long association with autoinflation treatment for glue ear. Our founder, Ian Ponsford, introduced Otovent Autoinflation Treatment to the UK in 1992, long before Kestrel Medical Ltd existed.

Recognising the product’s potential for improving patient outcomes and reducing the need for grommet operations, Ian and his children have worked hard and collaboratively with clinicians and researchers to increase adoption of Otovent within in clinical and appropriate self-care settings.

Otovent became available on prescription for children in 2003, was the subject of several key NHS studies in the 2010s, culminating in a 2016 NICE MedTech briefing.

It has subsequently been included in the NICE Guidelines for the Treatment of Glue Ear in Under 12s and remains the only clinically proven, non-surgical treatment for OME.

Otinova

Otitis Externa (Swimmer’s Ear)

Having worked closely with the manufacturer of Otovent for decades, we quickly adopted their new product for ear canal inflammation, Otinova.

Based on the proven Burow’s Solution formulation, Otinova is an over-the-counter treatment for otitis externa, formulated without antibiotics or steroids.

Since introducing Otinova to the UK in 2022, we have spoken with hundreds of clinicians about the challenges they and their patients face with treating otitis externa, while remaining conscious of antimicrobial stewardship.

Since then, NICE has listed Otinova as an astringent/acidic topical ear preparation, and we are looking forward to the results of a pilot study comparing Otinova with standard treatment (topical antibiotic drops) in patients with acute otitis externa.

Otinova
tinearity

Tinnitus in those with Normal Hearing

We have recently taken our first steps into the world of tinnitus treatments with the launch of Tinearity.

We are working closely with clinicians, patients and Tinnitus UK to build our expertise in the treatment landscape and experiences of those living with the condition.

Our priority is to ensure that healthcare professionals and patients have clear, balanced information about where Tinearity may have a role, and how it fits within wider tinnitus support and management.

Contact Us

If you have a query regarding any of our products or a question that is not covered in our FAQs, please feel free to get in touch.

Kestrel Medical







    Please tick this box to confirm that you are happy for your data to be used as described in our Privacy Policy: .